Anika Therapeutics reported $1.25M in Pre-Tax Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Abbott ABT:US $ 2982M 513M
Acceleron Pharma XLRN:US $ -70.45M 6.94M
Adamas Pharmaceuticals ADMS:US -19518000 7.17M
Agios Pharmaceuticals AGIO:US $ -84.26M 1.47M
Anika Therapeutics ANIK:US $ 1.25M 7.88M
Arrowhead Research ARWR:US $ -63.37M 33.45M
Chemocentryx CCXI:US $ -22.31M 16.9M
Clovis Oncology CLVS:US $ -67.4M 0.95M
Dicerna Pharmaceuticals DRNA:US $ -16.26M 24.01M
Enanta Pharmaceuticals ENTA:US $ -33.39M 0.01M
Flexion Therapeutics FLXN:US $ -30312000 8.1M
Halozyme Therapeutics HALO:US $ 74.11M 17.41M
Immunogen IMGN:US $ -37.34M 6.6M
Insmed INSM:US $ -115292000 1.41M
Intrexon XON:US $ -29.88M 9.76M
Johnson & Johnson JNJ:US $ 8058M 282M
Karyopharm Therapeutics KPTI:US $ -51706000 1.74M
Macrogenics MGNX:US $ -52.89M 12.95M
Peregrine Pharmaceuticals PPHM:US $ 3.52M 2.78M
Rigel Pharmaceuticals RIGL:US $ -21.09M 6.3M
Sangamo Biosciences SGMO:US $ -47.6M 0.45M
Surmodics SRDX:US $ -2.43M 0.94M
Veracyte VCYT:US $ -15.48M 24.67M
Xencor XNCR:US $ -40.19M 92.44M